Clinical Trial Update: A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering Drugs [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of darusentan in subjects with resistant systolic hypertension on three or more antihypertensive drugs. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Darusentan (darusentan)

Snippet

Sponsor: Gilead Sciences | Conditions: Hypertension | Phase 2 | Status: COMPLETED